Clinical significance of acquired somatic mutations in aplastic anaemia

Judith Marsh; Ghulam Mufti

doi:10.1007/s12185-016-1972-8

Clinical significance of acquired somatic mutations in aplastic anaemia

Judith Marsh^*, Ghulam Mufti

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

14 Citations (Scopus)

Abstract

Aplastic anaemia (AA) is frequently associated with other disorders of clonal haemopoiesis such as paroxysmal nocturnal haemoglobinuria (PNH), myelodysplastic syndrome (MDS) and T-large granular lymphocytosis. Certain clones may escape the immune attack within the bone marrow environment and proliferate and attain a survival advantage over normal haemopoietic stem cells, such as trisomy 8, loss of heterozygosity of short arm of chromosome 6 and del13q clones. Recently acquired somatic mutations (SM), excluding PNH clones, have been reported in around 20–25 % of patients with AA, which predispose to a higher risk of later malignant transformation to MDS/acute myeloid leukaemia. Furthermore, certain SM, such as ASXL1 and DNMT3A are associated with poor survival following immunosuppressive therapy, whereas PIGA, BCOR/BCORL1 predict for good response and survival. Further detailed and serial analysis of the immune signature in AA is needed to understand the pathogenetic basis for the presence of clones with SM in a significant proportion of patients.

Original language	English
Pages (from-to)	1-9
Number of pages	9
Journal	International Journal of Hematology
Early online date	18 Mar 2016
DOIs	https://doi.org/10.1007/s12185-016-1972-8
Publication status	E-pub ahead of print - 18 Mar 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s12185-016-1972-8

Cite this

@article{4149fd6679494588a753b32b6e37b54f,

title = "Clinical significance of acquired somatic mutations in aplastic anaemia",

abstract = "Aplastic anaemia (AA) is frequently associated with other disorders of clonal haemopoiesis such as paroxysmal nocturnal haemoglobinuria (PNH), myelodysplastic syndrome (MDS) and T-large granular lymphocytosis. Certain clones may escape the immune attack within the bone marrow environment and proliferate and attain a survival advantage over normal haemopoietic stem cells, such as trisomy 8, loss of heterozygosity of short arm of chromosome 6 and del13q clones. Recently acquired somatic mutations (SM), excluding PNH clones, have been reported in around 20–25 % of patients with AA, which predispose to a higher risk of later malignant transformation to MDS/acute myeloid leukaemia. Furthermore, certain SM, such as ASXL1 and DNMT3A are associated with poor survival following immunosuppressive therapy, whereas PIGA, BCOR/BCORL1 predict for good response and survival. Further detailed and serial analysis of the immune signature in AA is needed to understand the pathogenetic basis for the presence of clones with SM in a significant proportion of patients.",

author = "Judith Marsh and Ghulam Mufti",

year = "2016",

month = mar,

day = "18",

doi = "10.1007/s12185-016-1972-8",

language = "English",

pages = "1--9",

journal = "International Journal of Hematology",

issn = "0925-5710",

publisher = "Springer Japan",

}

TY - JOUR

T1 - Clinical significance of acquired somatic mutations in aplastic anaemia

AU - Marsh, Judith

AU - Mufti, Ghulam

PY - 2016/3/18

Y1 - 2016/3/18

N2 - Aplastic anaemia (AA) is frequently associated with other disorders of clonal haemopoiesis such as paroxysmal nocturnal haemoglobinuria (PNH), myelodysplastic syndrome (MDS) and T-large granular lymphocytosis. Certain clones may escape the immune attack within the bone marrow environment and proliferate and attain a survival advantage over normal haemopoietic stem cells, such as trisomy 8, loss of heterozygosity of short arm of chromosome 6 and del13q clones. Recently acquired somatic mutations (SM), excluding PNH clones, have been reported in around 20–25 % of patients with AA, which predispose to a higher risk of later malignant transformation to MDS/acute myeloid leukaemia. Furthermore, certain SM, such as ASXL1 and DNMT3A are associated with poor survival following immunosuppressive therapy, whereas PIGA, BCOR/BCORL1 predict for good response and survival. Further detailed and serial analysis of the immune signature in AA is needed to understand the pathogenetic basis for the presence of clones with SM in a significant proportion of patients.

AB - Aplastic anaemia (AA) is frequently associated with other disorders of clonal haemopoiesis such as paroxysmal nocturnal haemoglobinuria (PNH), myelodysplastic syndrome (MDS) and T-large granular lymphocytosis. Certain clones may escape the immune attack within the bone marrow environment and proliferate and attain a survival advantage over normal haemopoietic stem cells, such as trisomy 8, loss of heterozygosity of short arm of chromosome 6 and del13q clones. Recently acquired somatic mutations (SM), excluding PNH clones, have been reported in around 20–25 % of patients with AA, which predispose to a higher risk of later malignant transformation to MDS/acute myeloid leukaemia. Furthermore, certain SM, such as ASXL1 and DNMT3A are associated with poor survival following immunosuppressive therapy, whereas PIGA, BCOR/BCORL1 predict for good response and survival. Further detailed and serial analysis of the immune signature in AA is needed to understand the pathogenetic basis for the presence of clones with SM in a significant proportion of patients.

UR - http://www.scopus.com/inward/record.url?scp=84963762350&partnerID=8YFLogxK

U2 - 10.1007/s12185-016-1972-8

DO - 10.1007/s12185-016-1972-8

M3 - Article

AN - SCOPUS:84963762350

SN - 0925-5710

SP - 1

EP - 9

JO - International Journal of Hematology

JF - International Journal of Hematology

ER -

Clinical significance of acquired somatic mutations in aplastic anaemia

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this